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Congenital hemidysplasia with ichthyosiform
nevus and limb defects (CHILD) syndrome is an
exceedingly rare, X-linked dominant genetic disor-
der of lipid metabolism that arises frommutations in
NAD(P) dependent steroid dehydrogenase-like
gene (NSDHL), which encodes 3b-hydroxysteroid-
dehydrogenase, an enzyme essential to cholesterol
synthesis. Cholesterol plays a crucial role in hedge-
hog signaling during normal mammalian develop-
ment, thus explaining the striking right-to-left
unilateralism of both cutaneous and visceral man-
ifestations typified by this condition. Presenting at
birth or in the neonatal period, cutaneous findings
are unilateral erythema and scaling that progress to
increasingly hyperkeratotic, verrucous plaques or
bands, sometimes Blaschkoid; partial spontaneous
regression may occur over time. Skeletal defects,
ranging from hypoplasia to complete amelia, and
organ hypoplasia are likewise ipsilateral. CHILD
syndrome is predominantly seen in females, as it is
generally lethal in affected male embryos. In fact,
there are currently only 2 reported cases in the
literature of this disorder in males, one of whom we
saw for follow-up nearly 20 years after his original
description in 1996.1 Here we provide an update on
his clinical status and disease progression, as well as
advances in the current understanding of disease
pathogenesis and management of this rare
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A 24-year-old manwith CHILD syndrome (NSDHL
mutation c.262C[T, p.R88X)2,3 presented for follow-
up of right-sided, mildly pruritic, erythematous
ichthyosiform nevus sparing the face. The overall
area and distribution of involvement remained
relatively stable over the years without much spread
aside from slight expansion proportional to growth.
He was treated in the past with topical corticoste-
roids, emollients, retinoids, and azole antifungals
with minimal improvement. Dermabrasion of the
affected areas on the trunk was gratifying initially but
was ultimately nonsustained, with complete recur-
rence to original thickness within 8 months. The
patient is currently undergoing treatment with a 2%
simvastatin, 2% cholesterol compounded ointment
applied twice daily to existing lesions with signifi-
cant, sustained improvement.
The patient was born with a hypoplastic right leg
lacking a fibula. Correctional attempts were made to
salvage the lower leg, but he ultimately requiredJAAD Case Reports 2018;4:1010-3.
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Fig 1. CHILD syndrome in a man. Right-sided congenital nevus with scaling and erythema
involving the trunk (A) with Blaschkoid extension down the right anteromedial arm (B) and
groin (C) extending down the ipsilateral thigh (D) in the setting of above-the-knee amputation
for nonsalvageable lower limb defect.
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cations. Otherwise, no organ hypoplasia was found
at the time of initial description in 1996, with normal-
sized heart, brain, eyes, and kidneys noted. Nearly
20 years later, the patient remained in good health
overall without any chronic comorbid conditions or
medications.
On examination, there was a well-marginated
nevus involving the right thigh, groin, abdomenand chest extending down the right anteromedial
arm along Blaschko lines (Fig 1). The affected
areas on the thigh and groin were erythematous
and thickened with waxy, yellowish scale, espe-
cially overlying the thigh. The affected areas on the
abdomen and trunk were relatively clear in com-
parison, with faintly red-brown pigmentation and
without significant hyperkeratosis or thickening.
Periumbilically, to the right of midline, was a
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the right superior axillary fold was a curvilinear
hyperkeratotic band with erythematous and verru-
ciform accentuation centrally.DISCUSSION
CHILD syndrome is an X-linked dominant disor-
der of lipid metabolism that is usually lethal in males.
As such, the prevalence of this disorder in males is
exceedingly rare, as is the case in other X-linked
dominant disorders, such as incontinentia pigmenti.
For our patient, with normal 46, XY karyotype
identified on peripheral blood mononuclear cell
cytogenetic analysis, the proposed mechanism is an
acquired, postzygotic mutation in NSDHL with sub-
sequent mosaicism. Depending on the timing of his
mutation, this may account for the complete lack of
ipsilateral hemidysplasia of his internal organs,
which tend to develop at earlier Carnegie stages
relative to skeletal structures. Furthermore, the post-
zygotic mutation in our patient may have occurred
between days 22 and 55 of development, allowing
for initiation of central nervous system (CNS) and
kidney embryogenesis but not fibula development.
Interestingly, of the 33 reported cases of CHILD
syndrome in the literature, only 5 had internal organ
involvement beyond ipsilateral musculoskeletal hy-
poplasias.2-9 The most common organs involved
were the kidneys (3) and CNS (2), although lung,
vocal cord, and auditory nerve involvement were
also reported.
Specifically, a loss of function mutation in NSDHL
(encoding 3b-hydroxysteroid-dehydrogenase) on
Xq28 impairs cholesterol biosynthesis in the endo-
plasmic reticulum of keratinocytes.2,3 Deficits in
cholesterol cause a decrease in lamellar granules in
the stratum corneum of the epidermis, leading to
altered permeability of the skin characteristic of
ichthyosis. Buildup of cholesterol precursors lead
to reduced oxysterols and degeneration of HMG-
CoA (3-hydroxy-3-methyl-glutaryl-coenzyme A)
reductase, further exacerbating the decrease in
cholesterol production and subsequent epidermal
disruption.4 Impaired cholesterol biosynthesis also
disrupts the functioning of sonic hedgehog hormone
(SHH) in embryos, particularly in the development
of the appendicular skeleton and central nervous
system. Furthermore, signalingmolecules in the SHH
pathway are involved in dorsoventral axial
patterning and left-right asymmetry. Buildup of
harmful precursors of cholesterol synthesis contrib-
utes more to SHH dysfunction than does the lack of
cholesterol itself, although both do contribute. This
impairment explains the unilateral hypoplasiassometimes seen in the CNS and limbs of patients
with CHILD syndrome.10
Historical therapies for the cutaneous symptoms
of CHILD syndrome include topical ointments
(corticosteroids, emollients, retinoids, and azole
antifungals such as ketoconazole11), oral agents
(ketoconazole,11 retinoids, and methotrexate), and
surgical approaches (dermabrasion and skin graft-
ing). These treatments have varying degrees of
efficacy but do not address the underlying defect
in cholesterol.4 Skin grafting had been rather suc-
cessful because the unaffected donor graft does not
express the mutated allele and exhibits donor
dominance.12 However, this invasive approach
can be costly and is not feasible in patients with
nevi that take up large portions of their body
surface. Today, treatment with topical 2% statin
(lovastatin or simvastatin) and 2% cholesterol com-
pounded ointment was found to be effective in 8
patients treated over 6 case reports. Twice-daily
application for 6 months followed by 1 to 2 times
weekly for maintenance produced marked
improvement, with clinical improvement seen as
early as 3 weeks into treatment.4-9 This new
pathogenesis-directed therapy is a cost-effective
and noninvasive approach to treating the cutaneous
manifestations of CHILD syndrome.
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